Form 4: AnaptysBio Director Receives Equity Compensation
Insider Transaction Report
AnaptysBio Director Hollings Renton was granted 5,500 stock options and 4,000 restricted stock units.
Summary
- Hollings Renton, a Director of AnaptysBio, Inc. (ANAB), received an equity grant on January 6, 2026.
- The grant includes 5,500 stock options with an exercise price of $43.91 per share.
- These stock options will vest as to 1/12 of the total shares monthly, commencing on February 6, 2026, subject to continued service.
- Additionally, 4,000 Restricted Stock Units (RSUs) were granted.
- Each RSU represents a contingent right to receive one share of common stock upon settlement for no consideration.
- The RSUs will vest 100% on the date of the Issuer's 2027 annual meeting of shareholders, subject to continued service.
Sentiment
Score: 5
Explanation: The filing reports a routine equity compensation grant to a director, which is a neutral event in terms of immediate company performance or outlook.
Positives
- The equity grants align the Director's financial interests with those of the shareholders, incentivizing long-term performance.
- The vesting schedules for both stock options and RSUs are tied to the Director's continued service, promoting retention.
Related Party Transactions
- Grant of 5,500 stock options and 4,000 Restricted Stock Units to Hollings Renton, a Director of AnaptysBio, Inc.
Stakeholder Impact
- Shareholders: The equity grants align the Director's interests with long-term shareholder value creation.
- Employees (Reporting Person): The grants provide a significant component of compensation, contingent on continued service.
Next Steps
- Continued provision of service by the Reporting Person to the Issuer for vesting of equity awards.
- Monthly vesting of stock options commencing February 6, 2026.
- Vesting of Restricted Stock Units on the date of the Issuer's 2027 annual meeting of shareholders.
Key Dates
| Date | Description |
|---|---|
| 01/06/2026 | Date of transaction for both stock option and RSU grants. |
| 02/06/2026 | Commencement date for monthly vesting of stock options. |
| 01/05/2036 | Expiration date of the granted stock options. |
| 2027 Annual Meeting | Date when 100% of the Restricted Stock Units will vest. |
Keywords
ANAB, AnaptysBio, Form 4, Insider Transaction, Stock Options, Restricted Stock Units, Equity Grant, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.